736 related articles for article (PubMed ID: 21963997)
1. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
2. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice.
Yu L; Quinn DA; Garg HG; Hales CA
Circ Res; 2005 Oct; 97(9):937-45. PubMed ID: 16195480
[TBL] [Abstract][Full Text] [Related]
5. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
6. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
7. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
8. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
9. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
10. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
11. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
[TBL] [Abstract][Full Text] [Related]
12. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery.
Wu JR; Kao LP; Wu BN; Dai ZK; Wang YY; Chai CY; Chen IJ
Kaohsiung J Med Sci; 2015 May; 31(5):241-54. PubMed ID: 25910559
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
14. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Green DE; Murphy TC; Kang BY; Kleinhenz JM; Szyndralewiez C; Page P; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):718-26. PubMed ID: 22904198
[TBL] [Abstract][Full Text] [Related]
15. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Tan JX; Huang XL; Wang B; Fang X; Huang DN
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.
Hao M; Li M; Li W
Mol Med Rep; 2017 Jan; 15(1):160-168. PubMed ID: 27959409
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.
Chu Y; Xiangli X; Xiao W
Mol Med Rep; 2015 Apr; 11(4):3181-7. PubMed ID: 25523119
[TBL] [Abstract][Full Text] [Related]
18. [Effects of docosahexaenoic acid on hypoxia-induced pulmonary arterial hypertension].
Chen R; Liu P; Yan J; Gu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):109-12. PubMed ID: 24796591
[TBL] [Abstract][Full Text] [Related]
19. Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
Chu Y; XiangLi X; Niu H; Wang H; Jia P; Gong W; Wu D; Qin W; Xing C
Mol Cell Biochem; 2016 Jan; 412(1-2):91-9. PubMed ID: 26608181
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
